ArticleEndocrine2025
Safety profile of lanreotide: a retrospective post-marketing pharmacovigilance study based on the real-world data from FAERS database.
Yankun Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it